MURRIETA, CA--(Marketwire - March 31, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that the Board of Directors has met and approved CLX Medical, Inc. as the new name for the company, pending shareholder approval. The corporate name change requires majority shareholder approval before it can take effect, and the Board expects to initiate the process of gaining approval for the name change at the soonest practicable date.
